MDXH Financials: MDxHealth SA AI Analysis



Financials

MDXH Financial

MDxHealth SA

$2.04

-1.92%

$-0.04

As of today:Apr 28, 09:36:10 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$2.08

Open

$2.09

Day's Range

$2.02 - $2.11

52 week range

$1.47 - $5.33

Volume

159.7K

Avg.Volume

151.8K

Dividend yield

EPS (TTM)

-1.15

Market Cap

$55.6M

What is MDXH?

MDxHealth SA is a commercial-stage precision diagnostics company, which engages in the development and commercialization of molecular diagnostic products for personalized cancer treatment. The company is headquartered in Herstal, Liege and currently employs 312 full-time employees. The company went IPO on 2006-06-26. The Company’s tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, as well as prediction of response to a specific therapy. Its tests include ConfirmMDx for Prostate Cancer, SelectMDx for Prostate Cancer, PredictMDx for Glioblastoma and AssureMDx for Bladder Cancer. The firm's corporate operations are based in Herstal, Belgium, as well as Irvine, the United States, and its laboratory operations are based in Nijmegen, the Netherlands, as well as Irvine, the United States.

Features

Resources

Market

Income

Balance sheet

Cash flow

Annual

Quarterly

MDXH Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2025	09/30/2025	06/30/2025	03/31/2025	12/31/2024
Revenue	159	56	27	50	24	48
Revenue Growth (YoY)	20%	17%	17%	22%	26%	26%
Cost of Revenue	56	20	9	17	8	18
Gross Profit	103	36	17	33	15	29
Selling, General & Admin	103	37	18	31	15	31
Research & Development	14	5	2	5	2	5
Operating Expenses	124	44	20	39	20	40
Other Non Operating Income (Expenses)	-1	0	--	0	--	0
Pretax Income	-52	-18	-8	-16	-9	-17
Income Tax Expense	-1	-1	0	0	0	0
Net Income	-50	-16	-8	-16	-9	-18
Net Income Growth	-12%	-11%	-27%	-20%	13%	-10%
Shares Outstanding (Diluted)	50.42	50.42	50.06	49.49	48.46	38.43
Shares Change (YoY)	31%	31%	6%	83%	80%	48%
EPS (Diluted)	-1.02	-0.33	-0.16	-0.33	-0.19	-0.46
EPS Growth	-32%	-28%	-32%	-54%	-39%	-41%
Free Cash Flow	-3	0	1	-1	-3	-3
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	64.77%	64.28%	62.96%	66%	62.5%	60.41%
Operating Margin	-13.2%	-12.5%	-7.4%	-12%	-16.66%	-20.83%
Profit Margin	-31.44%	-28.57%	-29.62%	-32%	-37.5%	-37.5%
Free Cash Flow Margin	-1.88%	0%	3.7%	-2%	-12.5%	-6.25%
EBITDA	-12	-5	0	-4	-2	-8
EBITDA Margin	-7.54%	-8.92%	0%	-8%	-8.33%	-16.66%
D&A For EBITDA	9	2	2	2	2	2
EBIT	-21	-7	-2	-6	-4	-10
EBIT Margin	-13.2%	-12.5%	-7.4%	-12%	-16.66%	-20.83%
Effective Tax Rate	1.92%	5.55%	0%	0%	0%	0%

Follow-Up Questions

What are MDxHealth SA's key financial statements?



According to the latest financial statement (Form-10K), MDxHealth SA has a total asset of $0, Net loss of $0

What are the key financial ratios for MDXH?



MDxHealth SA's Current ratio is 0, has a Net margin is 0, sales per share of $0.

How is MDxHealth SA's revenue broken down by segment or geography?



MDxHealth SA largest revenue segment is Tissue-based, at a revenue of 81,491,000 in the most earnings release.For geography, United States, Europe and Rest of the World is the primary market for MDxHealth SA, at a revenue of 107,875,000.

Is MDxHealth SA profitable?



no, according to the latest financial statements, MDxHealth SA has a net loss of $0

Does MDxHealth SA have any liabilities?



no, MDxHealth SA has liability of 0

How many outstanding shares for MDxHealth SA?



MDxHealth SA has a total outstanding shares of 0

MDxHealth SA (MDXH) Financial

MDXH Stock Price Chart